Abstract
Introduction
Worldwide, 20–30 million people are estimated to be infected with HTLV. HTLV-1 is endemic in Western Africa and Southern Japan, whereas HTLV-2 is considered to be spread among native American people.
Materials and methods
The impact of HTLV in gynaecology and obstetrics is being reviewed. Search strategy and selection criteria for identifying relevant data were peformed by searching Medline, Current Contents, Web of Science, Embase and references from relevant articles. English and German gynaecological and infectious diseases textbooks as well as national and international guidelines and recommendations were also reviewed.
Results
Transmission may occur by sexual intercourse or cellular blood products. Although materno-fetal transmission is debated, transmission through maternal breast milk has been confirmed. An HTLV-infection can lead to adult T-cell leukaemia (ATL) or cumulative opportunistic and neurological disorders that can occur with varying degrees of severity. Diagnosis can be done by antibody detection via the use of ELISA and western blot analysis as well as PCR diagnosis.
Conclusion
Due to inadequate treatment options and the lack of an effective vaccination, prevention is currently only possible by restricting transmission, including the usage of condoms during sexual intercourse or avoiding breastfeeding in HTLV-seropositive mothers. If, due to socio-economic reasons, breastfeeding cannot be avoided, short-term breastfeeding for a maximum of up to 6 months is suggested.
Similar content being viewed by others
References
Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77:7415–7419
Proietti FA, Carneiro-Proietti AB (2006) HTLV in the Americas. Rev Panam Salud Publica 19:7–8
Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24:6058–6068
Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E (2007) Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 7:266–281
Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2:407–410
Gallo RC (1985) The human T-cell leukemia/lymphotropic retroviruses (HTLV) family: past, present, and future. Cancer Res 45:4524s–4533s
Bartholomew C, Jack N, Edwards J, Charles W, Corbin D, Cleghorn FR, Blattner WA (1998) HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis. J Hum Virol 1:302–305
Wilks R, Hanchard B, Morgan O, Williams E, Cranston B, Smith ML, Rodgers-Johnson P, Manns A (1996) Patterns of HTLV-I infection among family members of patients with adult T-cell leukemia/lymphoma and HTLV-I associated myelopathy/tropical spastic paraparesis. Int J Cancer 65:272–273
Gallo RC (2005) History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2. Oncogene 24:5926–5930
zur Hausen H (2009) Papillomaviruses in the causation of human cancers—a brief historical account. Virology 384:260–265
Jeang KT (2005) Retrovirology highlights a quarter century of HTLV-I research. Retrovirology 2:15
Manel N, Kim FJ, Kinet S, Taylor N, Sitbon M, Battini JL (2003) The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115:449–459
Gaudray G, Gachon F, Basbous J, Biard-Piechaczyk M, Devaux C, Mesnard JM (2002) The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol 76:12813–12822
Albrecht B, Lairmore MD (2002) Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis. Microbiol Mol Biol Rev 66:396–406 (Table of contents)
Bangham CR (2003) Human T-lymphotropic virus type 1 (HTLV-1): persistence and immune control. Int J Hematol 78:297–303
Zane L, Sibon D, Mortreux F, Wattel E (2009) Clonal expansion of HTLV-1 infected cells depends on the CD4 versus CD8 phenotype. Front Biosci 14:3935–3941
Umeki K, Hisada M, Maloney EM, Hanchard B, Okayama A (2009) Proviral loads and clonal expansion of HTLV-1-infected cells following vertical transmission: a 10-year follow-up of children in Jamaica. Intervirology 52:115–122
Tanaka G, Okayama A, Watanabe T, Aizawa S, Stuver S, Mueller N, Hsieh CC, Tsubouchi H (2005) The clonal expansion of human T lymphotropic virus type 1-infected T cells: a comparison between seroconverters and long-term carriers. J Infect Dis 191:1140–1147
Igakura T, Stinchcombe JC, Goon PK, Taylor GP, Weber JN, Griffiths GM, Tanaka Y, Osame M, Bangham CR (2003) Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 299:1713–1716
Saji F, Tokugawa Y, Kamiura S, Samejima Y, Ohashi K, Azuma C, Tanizawa O (1989) Vertical transmission of human T-cell leukemia virus type I (HTLV-I): detection of proviral DNA in HTLV-I carrier gravida. J Clin Immunol 9:409–414
Vandamme AM, Salemi M, Van Brussel M, Liu HF, Van Laethem K, Van Ranst M, Michels L, Desmyter J, Goubau P (1998) African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies. J Virol 72:4327–4340
Lemey P, Pybus OG, Van Dooren S, Vandamme AM (2005) A Bayesian statistical analysis of human T-cell lymphotropic virus evolutionary rates. Infect Genet Evol 5:291–298
Taylor GP, Bodeus M, Courtois F, Pauli G, Del Mistro A, Machuca A, Padua E, Andersson S, Goubau P, Chieco-Bianchi L, Soriano V, Coste J, Ades AE, Weber JN (2005) The seroepidemiology of human T-lymphotropic viruses: types I and II in Europe: a prospective study of pregnant women. J Acquir Immune Defic Syndr 38:104–109
Larsen O, Andersson S, da Silva Z, Hedegaard K, Sandstrom A, Naucler A, Dias F, Melbye M, Aaby P (2000) Prevalences of HTLV-1 infection and associated risk determinants in an urban population in Guinea-Bissau, West Africa. J Acquir Immune Defic Syndr 25:157–163
Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, Nass CC, Williams AE (2000) Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA 284:229–235
Kishihara Y, Furusyo N, Kashiwagi K, Mitsutake A, Kashiwagi S, Hayashi J (2001) Human T lymphotropic virus type 1 infection influences hepatitis C virus clearance. J Infect Dis 184:1114–1119
Price J, Cant BA, Barbara JA, Tedder RS (2001) Human T-cell leukaemia/lymphoma virus risk may be enhanced in some selected donor populations. Vox Sang 80:148–150
Zehender G, Colasante C, De Maddalena C, Bernini F, Savasi V, Persico T, Merli S, Ridolfo A, Santambrogio S, Moroni M, Galli M (2004) High prevalence of human T-lymphotropic virus type 1 (HTLV-1) in immigrant male-to-female transsexual sex workers with HIV-1 infection. J Med Virol 74:207–215
Lillo FB, Capiluppi B, Chiarolini A, McDermott JL, Varnier OE (1999) First report of the presence of human T-cell lymphotropic virus I infection in Italian drug addicts. Eur J Clin Microbiol Infect Dis 18:671–672
Paun L, Ispas O, Del Mistro A, Chieco-Bianchi L (1994) HTLV-I in Romania. Eur J Haematol 52:117–118
Shtalrid M, Shvidel L, Korenfeld R, Duek A, Landau Z, Berrebi A (2005) HTLV-1 associated adult T-cell leukemia/lymphoma in Israel: report of two patients of Romanian origin. Haematologica 90:ECR13
Gotuzzo E, Sanchez J, Escamilla J, Carrillo C, Phillips IA, Moreyra L, Stamm W, Ashley R, Roggen EL, Kreiss J et al (1994) Human T cell lymphotropic virus type I infection among female sex workers in Peru. J Infect Dis 169:754–759
Manns A, Wilks RJ, Murphy EL, Haynes G, Figueroa JP, Barnett M, Hanchard B, Blattner WA (1992) A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer 51:886–891
Osame M, Izumo S, Igata A, Matsumoto M, Matsumoto T, Sonoda S, Tara M, Shibata Y (1986) Blood transfusion and HTLV-I associated myelopathy. Lancet 2:104–105
Jason JM, McDougal JS, Cabradilla C, Kalyanaraman VS, Evatt BL (1985) Human T-cell leukemia virus (HTLV-I) p24 antibody in New York City blood product recipients. Am J Hematol 20:129–137
Sato H, Okochi K (1986) Transmission of human T-cell leukemia virus (HTLV-I) by blood transfusion: demonstration of proviral DNA in recipients’ blood lymphocytes. Int J Cancer 37:395–400
Siegel R, Gartenhaus R, Kuzel T (2001) HTLV-I associated leukemia/lymphoma: epidemiology, biology, and treatment. Cancer Treat Res 104:75–88
Tynell E, Andersson S, Lithander E, Arneborn M, Blomberg J, Hansson HB, Krook A, Nomberg M, Ramstedt K, Shanwell A, Bjorkman A (1998) Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis. BMJ 316:1417–1422
Lee HH, Weiss SH, Brown LS, Mildvan D, Shorty V, Saravolatz L, Chu A, Ginzburg HM, Markowitz N, Des Jarlais DC et al (1990) Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle Atlantic and central regions of the USA. J Infect Dis 162:347–352
Bassani S, Toro C, de la Fuente L, Brugal MT, Jimenez V, Soriano V (2004) Rate of infection by blood-borne viruses in active heroin users in 3 Spanish cities. Med Clin (Barc) 122:570–572
Zunt JR, Dezzutti CS, Montano SM, Thomas KK, Alarcon JO, Quijano E, Courtois BN, Sanchez JL, Campos P, Gotuzzo E, Guenthner PC, Lal RB, Holmes KK (2002) Cervical shedding of human T cell lymphotropic virus type I is associated with cervicitis. J Infect Dis 186:1669–1672
Kaplan JE, Khabbaz RF, Murphy EL, Hermansen S, Roberts C, Lal R, Heneine W, Wright D, Matijas L, Thomson R, Rudolph D, Switzer WM, Kleinman S, Busch M, Schreiber GB (1996) Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus epidemiology donor study group. J Acquir Immune Defic Syndr Hum Retrovirol 12:193–201
Roucoux DF, Wang B, Smith D, Nass CC, Smith J, Hutching ST, Newman B, Lee TH, Chafets DM, Murphy EL, Investigators HOS (2005) A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II. J Infect Dis 191:1490–1497
Figueroa JP, Ward E, Morris J, Brathwaite AR, Peruga A, Blattner W, Vermund SH, Hayes R (1997) Incidence of HIV and HTLV-1 infection among sexually transmitted disease clinic attenders in Jamaica. J Acquir Immune Defic Syndr Hum Retrovirol 15:232–237
Ureta-Vidal A, Angelin-Duclos C, Tortevoye P, Murphy E, Lepere JF, Buigues RP, Jolly N, Joubert M, Carles G, Pouliquen JF, de The G, Moreau JP, Gessain A (1999) Mother-to-child transmission of human T-cell-leukemia/lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothers. Int J Cancer 82:832–836
Li HC, Biggar RJ, Miley WJ, Maloney EM, Cranston B, Hanchard B, Hisada M (2004) Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I. J Infect Dis 190:1275–1278
Biggar RJ, Ng J, Kim N, Hisada M, Li HC, Cranston B, Hanchard B, Maloney EM (2006) Human leukocyte antigen concordance and the transmission risk via breast-feeding of human T cell lymphotropic virus type I. J Infect Dis 193:277–282
Tsuji Y, Doi H, Yamabe T, Ishimaru T, Miyamoto T, Hino S (1990) Prevention of mother-to-child transmission of human T-lymphotropic virus type-I. Pediatrics 86:11–17
Hirata M, Hayashi J, Noguchi A, Nakashima K, Kajiyama W, Kashiwagi S, Sawada T (1992) The effects of breastfeeding and presence of antibody to p40tax protein of human T cell lymphotropic virus type-I on mother to child transmission. Int J Epidemiol 21:989–994
Nyambi PN, Ville Y, Louwagie J, Bedjabaga I, Glowaczower E, Peeters M, Kerouedan D, Dazza M, Larouze B, van der Groen G, Delaporte E (1996) Mother-to-child transmission of human T-cell lymphotropic virus types I and II (HTLV-I/II) in Gabon: a prospective follow-up of 4 years. J Acquir Immune Defic Syndr Hum Retrovirol 12:187–192
Takezaki T, Tajima K, Ito M, Ito S, Kinoshita K, Tachibana K, Matsushita Y (1997) Short-term breast-feeding may reduce the risk of vertical transmission of HTLV-I. The Tsushima ATL study group. Leukemia 11(Suppl 3):60–62
Wiktor SZ, Pate EJ, Rosenberg PS, Barnett M, Palmer P, Medeiros D, Maloney EM, Blattner WA (1997) Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding. J Hum Virol 1:37–44
Hino S, Katamine S, Kawase K, Miyamoto T, Doi H, Tsuji Y, Yamabe T (1994) Intervention of maternal transmission of HTLV-1 in Nagasaki, Japan. Leukemia 8(Suppl 1):S68–S70
Kashiwagi K, Furusyo N, Nakashima H, Kubo N, Kinukawa N, Kashiwagi S, Hayashi J (2004) A decrease in mother-to-child transmission of human T lymphotropic virus type I (HTLV-I) in Okinawa, Japan. Am J Trop Med Hyg 70:158–163
Bittencourt AL, Dourado I, Filho PB, Santos M, Valadao E, Alcantara LC, Galvao-Castro B (2001) Human T-cell lymphotropic virus type 1 infection among pregnant women in northeastern Brazil. J Acquir Immune Defic Syndr 26:490–494
Caterino-de-Araujo A, de los Santos-Fortuna E (1999) No evidence of vertical transmission of HTLV-I and HTLV-II in children at high risk for HIV-1 infection from Sao Paulo, Brazil. J Trop Pediatr 45:42–47
Kinoshita K, Yamanouchi K, Ikeda S, Momita S, Amagasaki T, Soda H, Ichimaru M, Moriuchi R, Katamine S, Miyamoto T et al (1985) Oral infection of a common marmoset with human T-cell leukemia virus type-I (HTLV-I) by inoculating fresh human milk of HTLV-I carrier mothers. Jpn J Cancer Res 76:1147–1153
Miller GJ, Lewis LL, Colman SM, Cooper JA, Lloyd G, Scollen N, Jones N, Tedder RS, Greaves MF (1994) Clustering of human T lymphotropic virus type I seropositive in Montserrat, West Indies: evidence for an environmental factor in transmission of the virus. J Infect Dis 170:44–50
Yoshida M, Miyoshi I, Hinuma Y (1982) Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 76:2031–2035
Rodgers-Johnson P, Gajdusek DC, Morgan OS, Zaninovic V, Sarin PS, Graham DS (1985) HTLV-I and HTLV-III antibodies and tropical spastic paraparesis. Lancet 2:1247–1248
Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M (1986) HTLV-I associated myelopathy, a new clinical entity. Lancet 1:1031–1032
Verastegui E, Ortega V, Soler C, Lazo de la Vega S, Ocadiz R, Meneses A, Reynoso E, Alfaro G (1992) Primary B cell lymphoma of the rectum in a patient coinfected with HIV-1 and HTLV-I. Rev Invest Clin 44:387–392
Eguchi K, Nakamura T, Mine M, Ida H, Kawakami A, Migita K, Nagasato K, Kurata A, Fukuda T, Nagataki S (1992) HTLV-I associated arthritis: characteristics of an HTLV-I virus infected T cell line from synovial fluid. Ann Rheum Dis 51:673–677
Eguchi K, Origuchi T, Takashima H, Iwata K, Katamine S, Nagataki S (1996) High seroprevalence of anti-HTLV-I antibody in rheumatoid arthritis. Arthritis Rheum 39:463–466
Mochizuki M, Yamaguchi K, Takatsuki K, Watanabe T, Mori S, Tajima K (1992) HTLV-I and uveitis. Lancet 339:1110
Nakao K, Ohba N (1993) Clinical features of HTLV-I associated uveitis. Br J Ophthalmol 77:274–279
Nakao K, Ohba N, Nakagawa M, Osame M (1999) Clinical course of HTLV-I-associated uveitis. Jpn J Ophthalmol 43:404–409
Sugimoto M, Nakashima H, Kawano O, Ando M, Araki S (1989) Bronchoalveolar T-lymphocytosis in HTLV-1-associated myelopathy. Chest 95:708
Couderc LJ, Caubarrere I, Venet A, Magdeleine J, Jouanelle A, Danon F, Buisson G, Vernant JC (1988) Bronchoalveolar lymphocytosis in patients with tropical spastic paraparesis associated with human T-cell lymphotropic virus type 1 (HTLV-1): clinical, immunologic, and cytologic studies. Ann Intern Med 109:625–628
Nakada K, Yamaguchi K, Furugen S, Nakasone T, Nakasone K, Oshiro Y, Kohakura M, Hinuma Y, Seiki M, Yoshida M et al (1987) Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis. Int J Cancer 40:145–148
Primo JR, Brites C, Oliveira Mde F, Moreno-Carvalho O, Machado M, Bittencourt AL (2005) Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence. Clin Infect Dis 41:535–541
Bittencourt AL, Oliveira Mde F, Brites C, Van Weyenbergh J, da Silva Vieira MG, Araujo I (2005) Histopathological and immunohistochemical studies of infective dermatitis associated with HTLV-I. Eur J Dermatol 15:26–30
Matsuda T, Tomita M, Uchihara JN, Okudaira T, Ohshiro K, Tomoyose T, Ikema T, Masuda M, Saito M, Osame M, Takasu N, Ohta T, Mori N (2005) Human T cell leukemia virus type I-infected patients with Hashimoto’s thyroiditis and Graves’ disease. J Clin Endocrinol Metab 90:5704–5710
Sugimoto M, Nakashima H, Watanabe S, Uyama E, Tanaka F, Ando M, Araki S, Kawasaki S (1987) T-lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet 2:1220
Sabouri AH, Saito M, Usuku K, Bajestan SN, Mahmoudi M, Forughipour M, Sabouri Z, Abbaspour Z, Goharjoo ME, Khayami E, Hasani A, Izumo S, Arimura K, Farid R, Osame M (2005) Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals. J Gen Virol 86:773–781
Biswas HH, Engstrom JW, Kaidarova Z, Garratty G, Gibble JW, Newman BH, Smith JW, Ziman A, Fridey JL, Sacher RA, Murphy EL (2009) Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy. Neurology 73:781–789
Murphy EL, Wang B, Sacher RA, Fridey J, Smith JW, Nass CC, Newman B, Ownby HE, Garratty G, Hutching ST, Schreiber GB (2004) Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection. Emerg Infect Dis 10:109–116
Maloney EM, Cleghorn FR, Morgan OS, Rodgers-Johnson P, Cranston B, Jack N, Blattner WA, Bartholomew C, Manns A (1998) Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad. J Acquir Immune Defic Syndr Hum Retrovirol 17:167–170
Kaplan JE, Osame M, Kubota H, Igata A, Nishitani H, Maeda Y, Khabbaz RF, Janssen RS (1990) The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 3:1096–1101
Bittencourt AL, Sabino EC, Costa MC, Pedroso C, Moreira L (2002) No evidence of vertical transmission of HTLV-I in bottle-fed children. Rev Inst Med Trop Sao Paulo 44:63–65
Berger JR, Svenningsson A, Raffanti S, Resnick L (1991) Tropical spastic paraparesis-like illness occurring in a patient dually infected with HIV-1 and HTLV-II. Neurology 41:85–87
Jacobson S, Lehky T, Nishimura M, Robinson S, McFarlin DE, Dhib-Jalbut S (1993) Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Neurol 33:392–396
Orland JR, Engstrom J, Fridey J, Sacher RA, Smith JW, Nass C, Garratty G, Newman B, Smith D, Wang B, Loughlin K, Murphy EL, Study HO (2003) Prevalence and clinical features of HTLV neurologic disease in the HTLV outcomes study. Neurology 61:1588–1594
Hjelle B, Mills R, Swenson S, Mertz G, Key C, Allen S (1991) Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population. J Infect Dis 163:435–440
Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC (1982) A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 218:571–573
Poiesz B, Dube D, Dube S, Love J, Papsidero L, Uner A, Hutchinson R (2000) HTLV-II-associated cutaneous T-cell lymphoma in a patient with HIV-1 infection. N Engl J Med 342:930–936
Zucker-Franklin D, Hooper WC, Evatt BL (1992) Human lymphotropic retroviruses associated with mycosis fungoides: evidence that human T-cell lymphotropic virus type II (HTLV-II) as well as HTLV-I may play a role in the disease. Blood 80:1537–1545
Orland JR, Wang B, Wright DJ, Nass CC, Garratty G, Smith JW, Newman B, Smith DM, Murphy EL, Investigators H (2004) Increased mortality associated with HTLV-II infection in blood donors: a prospective cohort study. Retrovirology 1:4
Biswas HH, Kaidarova Z, Garratty G, Gibble JW, Newman BH, Smith JW, Ziman A, Fridey JL, Sacher RA, Murphy EL, for the HOS (2010) Increased All-Cause and Cancer Mortality in HTLV-II Infection. J Acquir Immune Defic Syndr (In press)
Thorstensson R, Albert J, Andersson S (2002) Strategies for diagnosis of HTLV-I and -II. Transfusion 42:780–791
Gallo D, Hoffman MN, Cossen CK, Diggs JL, Hurst JW, Penning LM (1988) Comparison of immunofluorescence, enzyme immunoassay, and western blot (immunoblot) methods for detection of antibody to human T-cell leukemia virus type I. J Clin Microbiol 26:1487–1491
Sabino EC, Zrein M, Taborda CP, Otani MM, Ribeiro-Dos-Santos G, Saez-Alquezar A (1999) Evaluation of the INNO-LIA HTLV I/II assay for confirmation of human T-cell leukemia virus-reactive sera in blood bank donations. J Clin Microbiol 37:1324–1328
Mangano AM, Remesar M, del Pozo A, Sen L (2004) Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate western blot patterns. J Med Virol 74:323–327
Vandamme AM, Van Laethem K, Liu HF, Van Brussel M, Delaporte E, de Castro Costa CM, Fleischer C, Taylor G, Bertazzoni U, Desmyter J, Goubau P (1997) Use of a generic polymerase chain reaction assay detecting human T-lymphotropic virus (HTLV) types I, II and divergent simian strains in the evaluation of individuals with indeterminate HTLV serology. J Med Virol 52:1–7
Dehee A, Cesaire R, Desire N, Lezin A, Bourdonne O, Bera O, Plumelle Y, Smadja D, Nicolas JC (2002) Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. J Virol Methods 102:37–51
Lee TH, Chafets DM, Busch MP, Murphy EL (2004) Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR green chemistry. J Clin Virol 31:275–282
Kamihira S, Dateki N, Sugahara K, Hayashi T, Harasawa H, Minami S, Hirakata Y, Yamada Y (2003) Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1-infected cell count. Clin Lab Haematol 25:111–117
Olindo S, Lezin A, Cabre P, Merle H, Saint-Vil M, Edimonana Kaptue M, Signate A, Cesaire R, Smadja D (2005) HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression. J Neurol Sci 237:53–59
Iwanaga M, Watanabe T, Utsunomiya A, Okayama A, Uchimaru K, Koh KR, Ogata M, Kikuchi H, Sagara Y, Uozumi K, Mochizuki M, Tsukasaki K, Saburi Y, Yamamura M, Tanaka J, Moriuchi Y, Hino S, Kamihira S, Yamaguchi K (2010) Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood (In press)
Trujillo L, Munoz D, Gotuzzo E, Yi A, Watts DM (1999) Sexual practices, prevalence of HIV, HTLV-I/II, and Treponema pallidum among clandestine female sex workers in Lima, Peru. Sex Transm Dis 26:115–118
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mylonas, I., Brüning, A., Kainer, F. et al. HTLV infection and its implication in gynaecology and obstetrics. Arch Gynecol Obstet 282, 493–501 (2010). https://doi.org/10.1007/s00404-010-1559-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-010-1559-1